NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
70 hedge funds and large institutions have $78M invested in Northwest Biotherapeutics, Inc. Common stock in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 71 → 70 (-1)
Holders
70
Holding in Top 10
1
Calls
$2.31M
Puts
$1.92M
Top Buyers
| 1 | +$1.23M | |
| 2 | +$1.15M | |
| 3 | +$770K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$518K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$465K |
Top Sellers
| 1 | -$5.16M | |
| 2 | -$1.18M | |
| 3 | -$929K | |
| 4 |
MAM
Majedie Asset Management
London,
United Kingdom
|
-$757K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$408K |